Specific blockade of TRPC1 and TRPC5 inhibited ERK/cAMP response element binding protein activation and provided neuroprotection.426 TRPCs have also been linked to Parkinson’s disease (PD) and Alzheimer’s disease (AD). This evidence concerns the gene TRPC5 and Parkinson disease.